ASTRAZENECA PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,594.00 GBX | -0.34% |
|
-1.38% | +1.32% |
| 09:36am | Stockholm Bullets - Millicom rises on new dividend policy | FW |
| 01-14 | Hutchmed lung cancer treatment Orpathys approved in China | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 201B | ||||||
| 671B | ||||||
| 363B | ||||||
| 349B | ||||||
| 310B | ||||||
| 252B |
- Stock Market
- Equities
- AZN Stock
- Charts AstraZeneca PLC
- Sector Chart
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition